In ALS, a measured ratio of C:N terminal TDP43 fragments >1.5 could differentiate ALS from control subjects in a study using post-mortem brain and spinal cord tissue [55]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.